[New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam]

Klin Med (Mosk). 1996;74(4):4-8.

[Article in Russian]

Authors

E L Nasonov¹, E S Tsvetkova, R M Balabanova, L N Denisov, L I Alekseeva, V A Nasonova

Affiliation

¹ Institute of Rheumatology, RAMN.

PMID: 8999152

No abstract available

Publication types

Review

MeSH terms

Animals
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Evaluation
Humans
Meloxicam
Prostaglandin-Endoperoxide Synthases / drug effects
Prostaglandin-Endoperoxide Synthases / metabolism
Prostaglandins / biosynthesis
Rheumatic Diseases / drug therapy*
Rheumatic Diseases / metabolism
Thiazines / therapeutic use*
Thiazoles / therapeutic use*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Prostaglandins
Thiazines
Thiazoles
Prostaglandin-Endoperoxide Synthases
Meloxicam